Literature DB >> 21273545

Smad4 is required predominantly in the developmental processes dependent on the BMP branch of the TGF-β signaling system in the embryonic mouse retina.

Deepa Murali1, Motoko Kawaguchi-Niida, Chu-Xia Deng, Yasuhide Furuta.   

Abstract

PURPOSE: The present study was aimed at defining developmental roles of Smad4, a key mediator of the TGF-β superfamily signaling system, in the embryonic mouse retina.
METHODS: Using a Cre/loxP-mediated conditional gene targeting approach, Smad4 gene function was deleted from the embryonic mouse retina. Mutant phenotypes were morphologically and molecularly examined.
RESULTS: Loss of Smad4 in the developing retina led to varying degrees of microphthalmia at birth, presumably because of elevated apoptosis observed transiently at embryonic day 12.5 in the developing retina. This was also associated with an apparent delay in accumulation of retinal ganglion cells. Smad4 conditional mutants also exhibited alterations of retinal spatial patterning along the dorsal-ventral axis, consistent with a known function of BMP signaling in the embryonic retina. However, despite a known role for BMP signaling in retinal cell survival, proliferation, and differentiation, Smad4 mutant retinal progenitor cells were capable of maintaining growth and neurogenesis throughout embryonic development. We also found that the loss of Smad4 led to abnormal targeting of retinal ganglion cell axons to the optic nerve head, a phenotype consistent with reduced BMP signaling in the developing retina.
CONCLUSIONS: These results suggest that Smad4 is essential for a subset of, but not all, TGF-β/BMP-dependent developmental processes in the embryonic retina. In addition, genetic requirements for Smad4 in the embryonic retina are evident predominantly in the developmental events regulated by the BMP branch of the TGF-β signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273545      PMCID: PMC3109008          DOI: 10.1167/iovs.10-5940

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  58 in total

Review 1.  How the Smads regulate transcription.

Authors:  Sarah Ross; Caroline S Hill
Journal:  Int J Biochem Cell Biol       Date:  2007-10-07       Impact factor: 5.085

2.  Gene regulation logic in retinal ganglion cell development: Isl1 defines a critical branch distinct from but overlapping with Pou4f2.

Authors:  Xiuqian Mu; Xueyao Fu; Phillip D Beremand; Terry L Thomas; William H Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-06       Impact factor: 11.205

3.  GDF11 controls the timing of progenitor cell competence in developing retina.

Authors:  Joon Kim; Hsiao-Huei Wu; Arthur D Lander; Karen M Lyons; Martin M Matzuk; Anne L Calof
Journal:  Science       Date:  2005-06-24       Impact factor: 47.728

4.  Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-beta/BMP signaling during tooth and palate development.

Authors:  Xun Xu; Jun Han; Yoshihiro Ito; Pablo Bringas; Chuxia Deng; Yang Chai
Journal:  Dev Cell       Date:  2008-08       Impact factor: 12.270

Review 5.  Emerging mechanisms in morphogen-mediated axon guidance.

Authors:  Cristina Sánchez-Camacho; Paola Bovolenta
Journal:  Bioessays       Date:  2009-10       Impact factor: 4.345

6.  Bone morphogenetic proteins, eye patterning, and retinocollicular map formation in the mouse.

Authors:  Daniel T Plas; Onkar S Dhande; Joshua E Lopez; Deepa Murali; Christina Thaller; Mark Henkemeyer; Yasuhide Furuta; Paul Overbeek; Michael C Crair
Journal:  J Neurosci       Date:  2008-07-09       Impact factor: 6.167

7.  SMAD proteins control DROSHA-mediated microRNA maturation.

Authors:  Brandi N Davis; Aaron C Hilyard; Giorgio Lagna; Akiko Hata
Journal:  Nature       Date:  2008-06-11       Impact factor: 49.962

8.  The spatial patterning of mouse cone opsin expression is regulated by bone morphogenetic protein signaling through downstream effector COUP-TF nuclear receptors.

Authors:  Shinya Satoh; Ke Tang; Atsumi Iida; Mariko Inoue; Tatsuhiko Kodama; Sophia Y Tsai; Ming-Jer Tsai; Yasuhide Furuta; Sumiko Watanabe
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

9.  TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta.

Authors:  Motozo Yamashita; Karoly Fatyol; Chaoyang Jin; Xiangchun Wang; Zhenggang Liu; Ying E Zhang
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

Review 10.  Non-Smad pathways in TGF-beta signaling.

Authors:  Ying E Zhang
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

View more
  6 in total

1.  Homozygous stop-gain variant in LRRC32, encoding a TGFβ receptor, associated with cleft palate, proliferative retinopathy, and developmental delay.

Authors:  Tamar Harel; Ephrat Levy-Lahad; Muhannad Daana; Hadas Mechoulam; Smadar Horowitz-Cederboim; Michal Gur; Vardiella Meiner; Orly Elpeleg
Journal:  Eur J Hum Genet       Date:  2019-04-11       Impact factor: 4.246

2.  The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina.

Authors:  Allen R Rodriguez; Luis Pérez de Sevilla Müller; Nicholas C Brecha
Journal:  J Comp Neurol       Date:  2014-04-15       Impact factor: 3.215

Review 3.  Genetic control of retinal ganglion cell genesis.

Authors:  Jianyi Lyu; Xiuqian Mu
Journal:  Cell Mol Life Sci       Date:  2021-03-29       Impact factor: 9.261

4.  Activation of BMP-Smad1/5/8 signaling promotes survival of retinal ganglion cells after damage in vivo.

Authors:  Yumi Ueki; Thomas A Reh
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

5.  Meis homeobox genes control progenitor competence in the retina.

Authors:  Naoko Dupacova; Barbora Antosova; Jan Paces; Zbynek Kozmik
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 12.779

6.  TGF-β Controls miR-181/ERK Regulatory Network during Retinal Axon Specification and Growth.

Authors:  Sabrina Carrella; Sara Barbato; Ylenia D'Agostino; Francesco Giuseppe Salierno; Anna Manfredi; Sandro Banfi; Ivan Conte
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.